During the past decade, Bryan LGH Medical Center East conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 7 clinical trials were completed, i.e. on average, 175% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bryan LGH Medical Center East" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "National Cancer Institute (NCI)" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Knopp Biosciences" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bryan LGH Medical Center East" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Bryan LGH Medical Center East" are "Amyotrophic Lateral Sclerosis" (2 trials), "Heart Failure" (2 trials), "Adenocarcinoma of the Colon" (1 trials), "Adenocarcinoma of the Prostate" (1 trials) and "Adult Anaplastic Oligodendroglioma" (1 trials). Many other conditions were trialed in "Bryan LGH Medical Center East" in a lesser frequency.

Most popular intervention types in "Bryan LGH Medical Center East" are "Drug" (9 trials), "Biological" (2 trials), "Device" (2 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (2 trials), "Placebo" (2 trials), "fluorouracil" (2 trials), "leucovorin calcium" (2 trials) and "oxaliplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bryan LGH Medical Center East" are 10 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Bryan LGH Medical Center East". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Bryan LGH Medical Center East, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Bryan LGH Medical Center East, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".